Logo image
Estrogen regulation of the brain renin-angiotensin system in protection against angiotensin II-induced sensitization of hypertension
Journal article   Open access

Estrogen regulation of the brain renin-angiotensin system in protection against angiotensin II-induced sensitization of hypertension

Baojian Xue, Zhongming Zhang, Terry G Beltz, Fang Guo, Meredith Hay and Alan Kim Johnson
American journal of physiology. Heart and circulatory physiology, Vol.307(2), pp.H191-H198
07/15/2014
DOI: 10.1152/ajpheart.01012.2013
PMCID: PMC4101642
PMID: 24858844
url
https://doi.org/10.1152/ajpheart.01012.2013View
Published (Version of record) Open Access

Abstract

This study investigated sex differences in the sensitization of angiotensin (ANG) II-induced hypertension and the role of central estrogen and ANG-(1-7) in this process. Male and female rats were implanted for telemetered blood pressure (BP) recording. A subcutaneous subpressor dose of ANG II was given alone or concurrently with intracerebroventricular estrogen, ANG-(1-7), an ANG-(1-7) receptor antagonist A-779 or vehicle for 1 wk (induction). After a 1-wk rest (delay), a pressor dose of ANG II was given for 2 wk (expression). In males and ovariectomized females, subpressor ANG II had no sustained effect on BP during induction, but produced an enhanced hypertensive response to the subsequent pressor dose of ANG II during expression. Central administration of estrogen or ANG-(1-7) during induction blocked ANG II-induced sensitization. In intact females, subpressor ANG II treatment produced a decrease in BP during induction and delay, and subsequent pressor ANG II treatment given during expression produced only a slight but significant increase in BP. However, central blockade of ANG-(1-7) by intracerebroventricular infusion of A-779 during induction restored the decreased BP observed in females during induction and enhanced the pressor response to the ANG II treatment during expression. RT-PCR analyses indicated that estrogen given during induction upregulated mRNA expression of the renin-angiotensin system (RAS) antihypertensive components, whereas both central estrogen and ANG-(1-7) downregulated mRNA expression of RAS hypertensive components in the lamina terminalis. The results indicate that females are protected from ANG II-induced sensitization through central estrogen and its regulation of brain RAS.
Estrogen Replacement Therapy Angiotensin II - administration & dosage Receptors, G-Protein-Coupled - metabolism Male RNA, Messenger - metabolism Brain - metabolism Peptidyl-Dipeptidase A - genetics Receptor, Angiotensin, Type 1 - genetics Time Factors Peptidyl-Dipeptidase A - metabolism Hypertension - prevention & control Female Blood Pressure - drug effects Hypertension - genetics Receptor, Angiotensin, Type 1 - drug effects Receptors, G-Protein-Coupled - drug effects Disease Models, Animal Proto-Oncogene Proteins - metabolism Proto-Oncogene Proteins - drug effects Ovariectomy Brain - physiopathology Peptide Fragments - administration & dosage Angiotensin I - administration & dosage Estradiol - administration & dosage Gene Expression Regulation Rats Proto-Oncogene Proteins - genetics Renin-Angiotensin System - genetics Angiotensin II - analogs & derivatives Telemetry Rats, Sprague-Dawley Hypertension - physiopathology Hypertension - metabolism Brain - drug effects Animals Receptor, Angiotensin, Type 1 - metabolism Sex Factors Renin-Angiotensin System - drug effects Receptors, G-Protein-Coupled - genetics Infusions, Intraventricular

Details

Metrics

Logo image